Related Experiment Video

Updated: Jun 27, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

The evolving role of C-reactive protein in atherothrombosis

Sridevi Devaraj1, Uma Singh, Ishwarlal Jialal

  • 1Laboratory for Atherosclerosis and Metabolic Research, University of California-Davis Medical Center, Sacramento, CA, USA.

Clinical Chemistry
|December 20, 2008
PubMed

Insights

C-reactive protein (CRP) is a key inflammation marker for cardiovascular events. Research suggests CRP not only predicts risk but also actively contributes to atherosclerosis development, requiring further investigation.

Area of Science:

  • Cardiovascular Science
  • Inflammation Biology
  • Atherosclerosis Research

Background:

  • Inflammation plays a critical role in all stages of atherosclerosis.
  • C-reactive protein (CRP) is a well-established inflammatory biomarker for cardiovascular events.
  • Evidence suggests CRP may actively participate in the process of atherogenesis.

Purpose of the Study:

  • To review the role of C-reactive protein (CRP) in promoting atherothrombosis.
  • To discuss the effects of CRP on key cellular components involved in atherosclerosis.

Main Methods:

  • Literature review focusing on the impact of CRP on endothelial cells.
  • Analysis of CRP's effects on endothelial progenitor cells.
  • Examination of CRP's influence on monocyte-macrophages and smooth muscle cells.

Main Results:

  • C-reactive protein (CRP) is a validated risk marker for cardiovascular disease.
  • CRP is recommended for primary prevention strategies in cardiovascular health.
  • CRP demonstrates potential to contribute directly to the development of atherosclerosis.

Conclusions:

  • CRP is a confirmed risk marker for cardiovascular disease, essential for primary prevention.
  • CRP appears to play a role in promoting atherogenesis.
  • Further research, particularly in animal models, is necessary to confirm CRP's role in atherothrombosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...